Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.
Micheli V, Regazzi M, Dickinson L, Meraviglia P, Villani P, Khoo SH, Viganò P, Cordier L, Cusato M, Duca P, Orlando G, Rizzardini G, Back DJ, Cargnel A. Micheli V, et al. Among authors: cordier l. Ther Drug Monit. 2008 Jun;30(3):306-13. doi: 10.1097/FTD.0b013e318177209e. Ther Drug Monit. 2008. PMID: 18520602 Free PMC article. Clinical Trial.
cART durability and causes for treatment switching or discontinuation in HIV-positive patients older than 50 years of age.
Orlando G, Meraviglia P, Valsecchi L, Mainini A, Schiavini M, Merli S, Cordier L, Angeli E, Giorgi R, Atzori C, Dedivitiis G, Beretta R, Fasolo M, Zampini L, Gubertini G, Fasan M, Zambelli A, Gulisano C, Mazza F, Minisci D, Ricci E, Rizzardini G. Orlando G, et al. Among authors: cordier l. J Acquir Immune Defic Syndr. 2010 Oct;55(2):e12-4. doi: 10.1097/QAI.0b013e3181ef791b. J Acquir Immune Defic Syndr. 2010. PMID: 20859084 No abstract available.
Linezolid for extensively drug-resistant tuberculosis.
Cattaneo D, Orlando G, Cordier L. Cattaneo D, et al. Among authors: cordier l. N Engl J Med. 2013 Jan 17;368(3):291. doi: 10.1056/NEJMc1214183. N Engl J Med. 2013. PMID: 23323919 No abstract available.
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.
Madeddu G, De Socio GV, Ricci E, Quirino T, Orofino G, Carenzi L, Franzetti M, Parruti G, Martinelli C, Vichi F, Penco G, Dentone C, Celesia BM, Maggi P, Libertone R, Bagella P, Di Biagio A, Bonfanti P; C.I.S.A.I. Group, Italy. Madeddu G, et al. Int J Antimicrob Agents. 2015 Mar;45(3):289-94. doi: 10.1016/j.ijantimicag.2014.10.013. Epub 2014 Nov 13. Int J Antimicrob Agents. 2015. PMID: 25476452
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA).
Taramasso L, Tatarelli P, Ricci E, Madeddu G, Menzaghi B, Squillace N, De Socio GV, Martinelli C, Gulminetti R, Maggi P, Orofino G, Vichi F, Di Biagio A, Bonfanti P; CISAI Study Group. Taramasso L, et al. BMC Infect Dis. 2018 Jul 31;18(1):357. doi: 10.1186/s12879-018-3268-5. BMC Infect Dis. 2018. PMID: 30064371 Free PMC article.
98 results